Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.63 $3.11 Thursday, 9th May 2024 ABUS stock ended at $2.94. This is 3.52% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 5.36% from a day low at $2.80 to a day high of $2.95.
90 days $2.30 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Jan 23, 2023 $2.79 $2.79 $2.68 $2.76 379 050
Jan 20, 2023 $2.68 $2.76 $2.65 $2.76 619 003
Jan 19, 2023 $2.60 $2.68 $2.60 $2.64 351 850
Jan 18, 2023 $2.83 $2.84 $2.65 $2.65 579 208
Jan 17, 2023 $2.83 $2.89 $2.76 $2.80 548 800
Jan 13, 2023 $2.87 $2.93 $2.82 $2.85 668 774
Jan 12, 2023 $2.70 $2.87 $2.67 $2.87 1 512 700
Jan 11, 2023 $2.74 $2.82 $2.68 $2.69 730 300
Jan 10, 2023 $2.68 $2.80 $2.65 $2.75 1 011 300
Jan 09, 2023 $2.52 $2.75 $2.51 $2.67 1 949 322
Jan 06, 2023 $2.29 $2.55 $2.27 $2.51 1 885 100
Jan 05, 2023 $2.23 $2.28 $2.15 $2.26 851 452
Jan 04, 2023 $2.28 $2.28 $2.22 $2.26 383 179
Jan 03, 2023 $2.35 $2.40 $2.22 $2.23 719 689
Dec 30, 2022 $2.28 $2.36 $2.26 $2.33 1 921 678
Dec 29, 2022 $2.22 $2.34 $2.22 $2.32 824 069
Dec 28, 2022 $2.31 $2.35 $2.20 $2.22 1 267 322
Dec 27, 2022 $2.39 $2.39 $2.26 $2.33 1 242 376
Dec 23, 2022 $2.39 $2.40 $2.33 $2.39 485 400
Dec 22, 2022 $2.42 $2.42 $2.32 $2.41 765 421
Dec 21, 2022 $2.40 $2.43 $2.35 $2.40 889 192
Dec 20, 2022 $2.44 $2.44 $2.32 $2.42 844 179
Dec 19, 2022 $2.71 $2.71 $2.41 $2.42 985 243
Dec 16, 2022 $2.70 $2.80 $2.61 $2.71 3 072 962
Dec 15, 2022 $2.66 $2.76 $2.65 $2.71 1 118 992
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT